FDA commissioner: Agency could approve coronavirus vaccine before phase 3 of trials are over
FDA commissioner Dr. Stephen Hahn says the agency could approve a coronavirus vaccine before the phase three trials are over, but that the benefits would have to outweigh the risks.
Share:
